Polatuzumab Vedotin Plus Rituximab, Ifosfamide, Carboplatin and Etoposide (Pola-R-ICE) Versus R-ICE Alone in Second Line Treatment of Diffuse Large B-cell Lymphoma (DLBCL)
Clinical trial NCT04833114 · COMPLETED
Trial details
- NCT number
- NCT04833114
- Sponsor
- GWT-TUD GmbH
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-30
- Primary completion
- 2025-12-19
- Enrollment
- 306
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.